Pathology News

Register now! Only one month to go until our webinar with Leica Biosystems, co-hosted by ACD! In this roundtable discussion, pathologists Rob Monroe, MD, PhD, and Jordan Laser M.D. provide an overview of RNAscope technology and how it is shaping the molecular in situ hybridization (ISH) testing landscape. Register here: 👉 https://lnkd.in/e-_-RnwK Attendees will see how RNAscope RNA ISH, coupled with automation capability on the BOND platform, takes ISH to the next level. What's more! This webinar will offer attendees the opportunity to earn self-reporting CME credits. We can't wait to welcome you on the 15th of November at 11:00 EST! #digitalpathology #pathologynews #webinar

Join the Aiforia Technologies webinar to discover how artificial intelligence is transforming anatomic pathology with groundbreaking advancements in diagnostics, prognostics, and therapeutic approaches. Maxwell L. Smith, M.D. and Lucas Stetzik will guide you through the powerful impact AI is having in pathology. Dr. Smith will share his experience developing two cutting-edge AI models using Aiforia® Create. First, he’ll showcase how AI is used to identify critical histologic features for diagnosing interstitial lung disease. Then, he’ll delve into how AI is enhancing the quantification of large droplet fat in frozen section pre-implant liver biopsies, a key step in liver transplantation. Register now to join this exciting event! Can’t attend live? No problem—we’ll send you a recording afterward so you won’t miss out. https://lnkd.in/etqUkzaQ #ArtificialIntelligence #Pathology #AiforiaWebinar #MedicalInnovation #AIinHealthcare #LungDisease #LiverTransplantation #AIDiagnostics

In our latest Thought Leaders episode, we're joined by Kirk Wojno, MD, and Jim Lu, MD PhD, Founder of DigitCells and GoPath Diagnostics. This episode tackles the transition from traditional to digital pathology, the pain points in molecular sendouts, and how the TWOD system reduces inefficiencies while enhancing diagnostic accuracy. From reducing mouse clicks to optimizing tissue workflow. This new Tissue Workflow Optimization for Digital (TWOD) system is designed to streamline lab operations and improve accuracy in digital pathology. By reducing the number of cassettes, slides, and digital images needed for prostate biopsies, TWOD enhances efficiency, minimizes errors, and keeps tissue orientation intact, allowing pathologists to diagnose with more confidence. The integration of barcode tracking from collection to analysis ensures no sample mix-ups, leading to better patient safety. You can watch or listen now using the link below: 👉 https://lnkd.in/gAVVrZFW #digitalpathology #pathologynews #TLS #interview

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, has announced a partnership with the Crohn's & Colitis Foundation. The collaboration will empower academic and biopharmaceutical researchers to unlock insights into inflammatory bowel disease (IBD) through the unique combination of quantitative histopathology data and well-characterized multi-modal clinical and molecular data. “We are thrilled to collaborate with the Crohn’s & Colitis Foundation, the leading nonprofit organization in the IBD space, as a preferred partner to meaningfully advance our understanding of IBD through this unique combination of datasets,” said Andrew Beck, MD, PhD, co-founder and CEO of PathAI. Quantitative histopathology data will be derived from the deployment of PathAI’s IBD Explore™ and AIM-HI UC™ algorithm products1 on digitized histology images from the Crohn’s and Colitis Foundation’s IBD PlexusⓇ dataset. The parties will also pursue collaborative research using their complementary assets aimed at advancing the field of IBD research. “By partnering with PathAI, we aim to uncover valuable insights from well-characterized pathology images, enhancing our understanding of IBD at the microscopic level and paving the way for novel biomarkers, refined disease subtypes, and potential therapeutic targets,” said Angela Dobes, SVP IBD Plexus, Crohn’s & Colitis Foundation. Read the article in full on Pathology News using the link below: https://lnkd.in/eA5wd-SE #digitalpathology #pathologynews #webinar

Stratipath has partnered with Roche to distribute its AI-based breast cancer risk stratification tool, Stratipath Breast, through Roche’s navify® Digital Pathology software. The solution uses deep learning to analyze histopathology images, offering faster and more affordable prognostic insights compared to traditional molecular tests, improving accessibility for pathology labs globally. This collaboration advances breast cancer diagnostics by integrating AI and digital pathology to enhance risk assessments. Stratipath and Roche aim to improve patient outcomes worldwide by providing more efficient and accessible tools for clinicians. Read more on Pathology News: https://lnkd.in/eNgQM3vx #digitalpathology #pathologynews

Join Proscia for an insightful panel discussion on the transformative potential of pathology real-world data (RWD). As diagnostic workflows become digitized, each pathology image holds billions of pixels and untapped insights that can accelerate drug discovery and development. Industry experts, including Derek Welch, Ben Freiberg, and Nathan Buchbinder, will share how they are utilizing this data to drive the next breakthroughs in precision medicine. Attendees will gain a clear understanding of how RWD is advancing precision medicine diagnostics and therapies, illustrated through real-world examples and practical use cases. The panel will also provide expert perspectives on the growing impact of RWD as digital pathology adoption continues to rise. Additionally, attendees will develop a deeper appreciation for the critical role clinical laboratories play, not only in delivering today’s precision diagnostics but in shaping the future of novel diagnostics and therapies. Find out more on Pathology News: https://lnkd.in/eX4eaJr5 #digitalpathology #pathologynews

Pathology News's new headline article highlights a groundbreaking study from researchers at GCS INSTITUT UNIVERSITAIRE DU CANCER ONCOPOLE-and Université Paul Sabatier Toulouse III, who developed two innovative methods to reduce stain color bias in histopathology images used for AI training. Their approaches, AugmentHE for stain color augmentation and HEnorm for image normalization, address the inconsistencies in staining techniques across laboratories, enhancing AI model performance. Tested on breast cancer images from three clinical trials, these methods reduced bias and improved model accuracy by up to 21.7%. The combination of normalization and augmentation proved the most effective strategy for overcoming stain variability. These open-source tools offer critical advancements for digital pathology and AI applications in healthcare. Read the full article on Pathology News: https://lnkd.in/epc3SK8U #digitalpathology #pathologynews

Thank you to everyone who joined us last Thursday for our webinar with Indica Labs, focusing on HALO AP® and HALO AP Dx. We thoroughly enjoyed the session and appreciated the insightful questions from the audience. If you weren't able to make it, the on-demand video is now available via the link below. 🔗 https://lnkd.in/efsJRf4T We look forward to welcoming you to our next webinar with Leica Biosystems on the 15th of November! See you there! #digitalpathology #pathologynews #webinar

The Pathology News team is thrilled to offer our readers another event discount! 🎁 The European Society for Spatial Biology (ESSB) is hosting its annual conference in Berlin on December 12 and 13, 2024. This event will bring together an interdisciplinary audience from various life science fields, including but not limited to pathologists, neuroscientists, tumor immunologists, and developmental biologists. Participants at all levels of expertise, such as doctoral researchers, postdoctoral fellows, and principal investigators, are expected to attend. Use the link below and the discount codes to secure exclusive early-bird rates on registration: - ESSB-2024_A - ESSB2024_student As a unique offering, the conference will provide childcare services, generously sponsored by Bruker. If you require this service, please indicate so when registering. 🔗 https://lnkd.in/er7C4KPy #pathologynews #digitalpathology

Aiosyn invites you to a 45-minute webinar that looks into the challenges of manual quality control (QC) in digital pathology and the transformative potential of AI-powered technology. Led by Aiosyn’s AI Engineer, Błażej Dolicki, and sales specialist, Nikolai Born, the session will highlight how AI enhances manual workflows by automating artifact detection. Real-world examples of AiosynQC in action will be presented, showcasing its ability to analyze digital slides from pixel-level detail to high-level QC decisions. Attendees will discover the benefits of AiosynQC, including improved diagnostic quality and reduced time spent on quality control. The webinar will also explore how AiosynQC easily integrates with existing workflows through flexible deployment options and tailored sensitivity. Key topics include the limitations of manual QC, AI’s role in enhancing this process, customer case studies, and the practical advantages of AiosynQC in streamlining QC and ensuring high-quality slides. To find out more visit Pathology News: https://lnkd.in/eHJ_Menu #digitalpathology #pathologynews